Resistance to Molecular Therapies for Hepatocellular Carcinoma /
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2017.
|
| Edition: | 1st ed. 2017. |
| Series: | Resistance to Targeted Anti-Cancer Therapeutics,
13 |
| Subjects: |
Table of Contents:
- Tumor Heterogeneity and Resistance to Targeted Therapies in Hepatocellular Carcinoma
- Modulating Immune Responses to Overcome Resistance in Hepatocellular Carcinoma
- Role of Tumor Microenvironment in Hepatocellular Carcinoma Resistance
- Contribution of the Cancer Stem Cell Phenotype to Hepatocellular Carcinoma Resistance
- Clinical and Preclinical Perspectives on Mechanisms of Sorafenib Resistance in Hepatocellular Carcinoma
- Radiological Assessment of Response to Palliative Treatments in Hepatocellular Carcinoma
- Sorafenib and Clinical Patterns of Resistance in hepatocellular carcinoma
- Overcoming Treatment Resistance in Hepatocellular Carcinoma: regorafenib and lessons from other malignancies.